Community Health Systems (NYSE:CYH) shares traded -1.06% down during most recent session to reach at the closing price of $8.44. The stock exchanged hands 3.08 Million shares versus average trading capacity of 3.36 Million shares, yielding a market cap of $961.15 Million. Wall Street analysts covering the stock are projecting that the stock will reach $9.89 within the next 52-weeks. The mean target projections are based on 19 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Community Health Systems (NYSE:CYH) high price target of $14 and with a conservative view have low price target of $5.
Morgan Stanley “Initiates Coverage On” Community Health Systems (NYSE:CYH) in a research note issued to investors on 6/07/17 to Underweight with price target of $9.5.
Additionally on 4/05/17 Deutsche Bank “Initiates Coverage On” Community Health Systems (NYSE:CYH) to Hold setting price target at $11 and on 3/01/17 PiperJaffray “Downgrades” the stock to Underweight at $0. Furthermore on 2/22/17 Baird “Upgrades” the stock to Neutral at $9.
On the other hand the company has Relative Strength Index (RSI 14) of 35.82 along with Average True Range (ATR 14) of 0.45, Consequently Community Health Systems (NYSE:CYH)’s weekly and monthly volatility is 5.09%, 4.35% respectively. The company’s beta value is at 1.69.
In terms of Buy, Sell or Hold recommendations, Community Health Systems (NYSE:CYH) has analysts’ mean recommendation of 3.1. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Community Health Systems (NYSE:CYH)’s minimum EPS for the current quarter is at $-0.06 and can go high up to $0.21. The consensus mean EPS for the current quarter is at $0.08 derived from a total of 21 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.09 earnings per share for the same quarter during last year.
Previously Community Health Systems (NYSE:CYH) reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.01. The company posted an earnings surprise of 14.3%.
While considering growth estimates of the company, it has next quarter growth estimates of 100% whereas during current quarter it has -11.1% estimations over growth, comparing to the estimations of -17.4% during current year and 126.3% for next year. Past 5 years growth of Community Health Systems (NYSE:CYH) observed at -24.33%, looking forward for the next 5 years it has a strong prediction of 11.51% over growth.
Community Health Systems (NYSE:CYH)’s revenue estimates for the current quarter are $4.06 Billion according to 17 number of analysts, for the current quarter the company has high revenue estimates of $4.25 Billion in contradiction of low revenue estimates of $3.79 Billion. For the current year the company’s revenue estimates are $16.02 Billion compared to low analyst estimates of $15.81 Billion and high estimates of $16.18 Billion according to 18 number of analysts.
Currently Community Health Systems (NYSE:CYH)’s shares owned by insiders are 3.3%, whereas shares owned by institutional owners are 99.2%. However the six-month change in the insider ownership was recorded -0.05%, as well as three-month change in the institutional ownership was recorded -0.28%.
Community Health Systems (NYSE:CYH) 52-week high price stands at $15.16 and low price stands at $4.15, its price distance from 52-week high is -44.33% while its distance from 52-week low price is 103.37%. The stock hit its 52-week high on 06/13/16, and 52-week low on 11/09/16.
Community Health Systems (NYSE:CYH)’s trailing twelve month revenues are $17.93 Billion, whereas its price to sales ratio for the same period is 0.05. Its book value per share for the most recent quarter is $12.84 while its price to book ratio for the same period is 0.66, as for as the company’s cash per share for the most recent quarter is $2.17, however its price to cash per share ratio for the same period is 3.89. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.